Details for Patent: 11,701,330
✉ Email this page to a colleague
Which drugs does patent 11,701,330 protect, and when does it expire?
Patent 11,701,330 protects EPIDIOLEX and is included in one NDA.
This patent has forty-eight patent family members in eleven countries.
Drugs Protected by US Patent 11,701,330
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH LENNOX-GASTAUT SYNDROME | ⤷ Sign Up | ||||
| Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH DRAVET SYNDROME | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,701,330
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015275886 | ⤷ Sign Up | |||
| Australia | 2015275887 | ⤷ Sign Up | |||
| Australia | 2020217417 | ⤷ Sign Up | |||
| Australia | 2020220135 | ⤷ Sign Up | |||
| Australia | 2022202119 | ⤷ Sign Up | |||
| Australia | 2022209295 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
